Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
MasterCard
MA
5
American Express
AXP
CA Stock MarketDetailed Quotes
QNTM Quantum BioPharma Ltd
- 11.780
- +1.180+11.13%
15min DelayMarket Closed May 5 15:56 ET
3.52MMarket Cap-0.62P/E (TTM)
11.970High10.890Low7.86KVolume10.890Open10.600Pre Close89.88KTurnover25.64052wk High2.63%Turnover Ratio298.81KShares3.90052wk Low-18.871EPS TTM3.52MFloat Cap25.640Historical HighLossP/E (Static)298.81KShs Float3.900Historical Low-18.871EPS LYR10.19%Amplitude--Dividend TTM0.22P/B1Lot Size--Div YieldTTM
About Quantum BioPharma Ltd Company
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
Company Profile
SymbolQNTM
Company NameQuantum BioPharma Ltd
Founded1994
MarketCNQ
Employees7
Fiscal Year Ends12-31
Address55 University Avenue Suite 1003
CityToronto
CountryCAN
Zip CodeM5J 2H7
Phone+1 844 978-3540
Websitehttps://www.fsdpharma.com
Company Executives
- Name
- Position
- Salary
- Zeeshan Saeed
- Chief Executive Officer, Co-Executive Chairman of the Board and President
- 583.69K
- Dr. Lakshmi P. Kotra
- Director, Chief Executive Officer, Lucid, President, FSD Biosciences and Chief Executive Officer, FSD Australia
- 59.79K
- Donal Carroll
- Chief Financial Officer
- 583.69K
- Anthony Durkacz
- Executive Co-Chairman of the Board
- 583.69K
- Dr. Andrzej Chruscinski
- Vice-President, Clinical and Scientific Affairs
- --
- Dr. Ashwini Joshi
- Director, Pharmaceutical Development
- --
- Terry Lynch
- Independent Director
- --
- Michael Zapolin
- Independent Director
- 49.32K
- Adnan Bashir
- Independent Director
- 43.73K
- Dr. Eric Hoskins
- Independent Director
- 65.83K
- Nathan Coyle
- Controller
- 104.92K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting